Fenofibrate ameliorates diabetic retinopathy by modulating Nrf2 signaling and NLRP3 inflammasome activation.

about

Remodeling of Retinal Architecture in Diabetic Retinopathy: Disruption of Ocular Physiology and Visual Functions by Inflammatory Gene Products and Pyroptosis

P2860

Q58762933-A0258B01-2E88-46DD-8C9E-A1C910BF403E

P2860

Fenofibrate ameliorates diabetic retinopathy by modulating Nrf2 signaling and NLRP3 inflammasome activation.

Item

http://www.wikidata.org/entity/Q48372368

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Fenofibrate ameliorates diabet ...... NLRP3 inflammasome activation.

@en

Fenofibrate ameliorates diabet ...... NLRP3 inflammasome activation.

@nl

type

Item

label

Fenofibrate ameliorates diabet ...... NLRP3 inflammasome activation.

@en

Fenofibrate ameliorates diabet ...... NLRP3 inflammasome activation.

@nl

prefLabel

Fenofibrate ameliorates diabet ...... NLRP3 inflammasome activation.

@en

Fenofibrate ameliorates diabet ...... NLRP3 inflammasome activation.

@nl

P1476

Fenofibrate ameliorates diabet ...... NLRP3 inflammasome activation.

@en

P2093

Fengjun Zhang

http://www.w3.org/2001/XMLSchema#string

Jian-Xing Ma

http://www.w3.org/2001/XMLSchema#string

Jinglin Yi

http://www.w3.org/2001/XMLSchema#string

Qiuping Liu

http://www.w3.org/2001/XMLSchema#string

Rui Cheng

http://www.w3.org/2001/XMLSchema#string

Xian Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

The importance of glial cells in the homeostasis of the retinal microenvironment and their pivotal role in the course of diabetic retinopathy

Inflammation and metabolic disorders

Thioredoxin-interacting protein links oxidative stress to inflammasome activation

The pathobiology of diabetic complications: a unifying mechanism

NRF2 plays a protective role in diabetic retinopathy in mice

Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial.

Effects of medical therapies on retinopathy progression in type 2 diabetes

Inhibition of reactive oxygen species by Lovastatin downregulates vascular endothelial growth factor expression and ameliorates blood-retinal barrier breakdown in db/db mice: role of NADPH oxidase 4.

The inflammasome: first line of the immune response to cell stress.

Peroxisome proliferator-activated receptor α protects capillary pericytes in the retina.

P2888

s11010-017-3256-x

P304

105-115

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11010-017-3256-X

http://www.w3.org/2001/XMLSchema#string

P433

1-2

http://www.w3.org/2001/XMLSchema#string

P478

445

http://www.w3.org/2001/XMLSchema#string

P50

Jingming Li

P577

2017-12-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29264825

http://www.w3.org/2001/XMLSchema#string

P921

inflammasome

Fenofibrate ameliorates diabetic retinopathy by modulating Nrf2 signaling and NLRP3 inflammasome activation.

about

P2860

P2860

Fenofibrate ameliorates diabetic retinopathy by modulating Nrf2 signaling and NLRP3 inflammasome activation.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921